-
1.Diketohydrazine derivative compound and medicine containing the compound as active ingredient 有权
标题翻译: 酮衍生物衍生化合物和含有化合物作为活性成分的药物公开(公告)号:JP2006199703A
公开(公告)日:2006-08-03
申请号:JP2006046815
申请日:2006-02-23
申请人: Ono Pharmaceut Co Ltd , 小野薬品工業株式会社
发明人: HATAKEYAMA AKIRA , TSURUTA KOJI , OCHI YASUO , IMAWAKA HARUO , OMOTO KAZUYUKI
IPC分类号: C07C243/24 , C07C243/34 , A61K31/16 , A61K31/165 , A61K31/197 , A61K31/341 , A61K31/351 , A61K31/40 , A61K31/4015 , A61K31/4025 , A61K31/4035 , A61K31/4152 , A61K31/4166 , A61K31/4168 , A61K31/4188 , A61K31/421 , A61K31/423 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/429 , A61K31/4402 , A61K31/454 , A61K31/5375 , A61P1/16 , A61P3/00 , A61P3/14 , A61P7/00 , A61P9/00 , A61P11/00 , A61P19/00 , A61P19/02 , A61P19/08 , A61P19/10 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/00 , A61P43/00 , C07C251/76 , C07C251/84 , C07C251/86 , C07D207/22 , C07D207/263 , C07D207/404 , C07D207/50 , C07D209/46 , C07D209/48 , C07D211/28 , C07D211/72 , C07D211/86 , C07D211/98 , C07D213/53 , C07D213/70 , C07D213/76 , C07D213/77 , C07D213/78 , C07D231/08 , C07D233/38 , C07D233/52 , C07D233/80 , C07D239/10 , C07D239/18 , C07D239/36 , C07D241/08 , C07D241/18 , C07D263/26 , C07D263/28 , C07D265/08 , C07D265/10 , C07D265/32 , C07D265/33 , C07D275/02 , C07D275/03 , C07D275/06 , C07D277/18 , C07D277/36 , C07D277/50 , C07D277/54 , C07D277/60 , C07D277/82 , C07D279/02 , C07D279/06 , C07D279/12 , C07D285/10 , C07D285/16 , C07D307/52 , C07D309/04 , C07D309/20 , C07D309/28 , C07D335/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D487/04 , C07D513/10 , C07F9/59 , C07F9/6558
CPC分类号: C07D209/48 , A61K31/16 , A61K31/165 , A61K31/341 , A61K31/351 , A61K31/40 , A61K31/4025 , A61K31/4035 , A61K31/4152 , A61K31/4166 , A61K31/4168 , A61K31/421 , A61K31/423 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/429 , C07C243/34 , C07C251/76 , C07C251/84 , C07C251/86 , C07C2601/08 , C07C2601/14 , C07D207/22 , C07D207/50 , C07D209/46 , C07D211/28 , C07D211/72 , C07D211/86 , C07D211/98 , C07D213/70 , C07D213/76 , C07D213/77 , C07D213/78 , C07D233/38 , C07D233/52 , C07D233/80 , C07D239/10 , C07D239/18 , C07D239/36 , C07D241/08 , C07D241/18 , C07D263/26 , C07D263/28 , C07D265/08 , C07D265/10 , C07D265/33 , C07D275/02 , C07D275/03 , C07D275/06 , C07D277/18 , C07D277/36 , C07D277/50 , C07D277/54 , C07D277/60 , C07D277/82 , C07D279/02 , C07D279/06 , C07D279/12 , C07D285/10 , C07D285/16 , C07D309/04 , C07D309/28 , C07D335/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D513/10 , C07F9/591 , C07F9/65583
摘要: PROBLEM TO BE SOLVED: To provide a compound represented by the general formula (I), which has a cysteine protease-inhibiting activity, is useful for the treatment of inflammatory diseases, immune diseases, ischemic diseases, respiratory diseases, circulatory diseases, blood diseases, neuronal diseases, hepatic or biliary diseases, bone or articular diseases, metabolic diseases, etc., and is also useful for the treatment of COPD (chronic obstacle pulmonary diseases) because of having an inhibitory activity against elastase. SOLUTION: This medicine composition contains a diketohydrazine derivative represented by the general formula (I) or its pharmaceutically acceptable salt. COPYRIGHT: (C)2006,JPO&NCIPI
摘要翻译: 待解决的问题:提供具有半胱氨酸蛋白酶抑制活性的由通式(I)表示的化合物可用于治疗炎性疾病,免疫疾病,缺血性疾病,呼吸系统疾病,循环系统疾病 血液疾病,神经元疾病,肝或胆道疾病,骨或关节疾病,代谢疾病等,并且由于对弹性蛋白酶具有抑制活性,因此也可用于治疗COPD(慢性阻塞性肺疾病)。 解决方案:该药物组合物含有由通式(I)表示的二酮肼衍生物或其药学上可接受的盐。 版权所有(C)2006,JPO&NCIPI